January 24, 2024 11:11 AM EST
News Briefing

Ku­ra’s $150M PIPE; Lil­ly’s in­vest­ment in Prism Bi­o­Lab; An­no­vis de­lays PhI­II da­ta, cit­ing ‘da­ta clean­ing’

Lei Lei Wu

News Reporter

Jaimy Lee

Deputy Editor

Plus, news about IMU Bio­sciences, ZWI Ther­a­peu­tics and Sagimet Bio­sciences:

Ku­ra On­col­o­gy’s $150M PIPE: The biotech is rais­ing funds from a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times